Surgical strategies for BPH in the UK: an economic analysis
- PDF / 142,832 Bytes
- 1 Pages / 623.591 x 841.847 pts Page_size
- 25 Downloads / 175 Views
Strategy: TURPa DV HoLEP DV + HoLEP DV + TURPa
Incremental cost
Incremental effectiveness
ICER
(£1000s)
(QALYs)
(£/QALY)
39 602 0 19 775 13 163 4551
-751 0 2574 1385 50
Dominated n/a 7682 9505 90 576
repeated once if necessary TURP = transurethral resection of prostate; DV = diathermy vaporisation; HOLEP = holmium laser enucleation
a
At a set willingness to pay threshold of £20 000, the DV plus HoLEP strategy was predicted to have an 85% chance of being cost effective; in comparison, DV alone, HoLEP alone, TURP alone and DV plus TURP, were predicted to have 0%, 11%, 4% and 0% chances, respectively. The researchers noted that "sensitivity analysis around appropriately selected variables did not radically change key outcomes of the model". Armstrong N, et al. Surgical treatments for men with benign prostatic enlargement: cost effectiveness study. BMJ 338: 1187-1190, No. 7704, 16 May 801140018 2009
1173-5503/10/0577-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved
PharmacoEconomics & Outcomes News 2 May 2009 No. 577
1
Data Loading...
